The significance of hematologic abnormalities in patients with tuberculosis. 1970

R M Glasser, and R I Walker, and J C Herion

UI MeSH Term Description Entries
D007964 Leukocytosis A transient increase in the number of leukocytes in a body fluid. Pleocytosis,Leukocytoses,Pleocytoses
D007970 Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). Leukocytopenia,Leukocytopenias,Leukopenias
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D006402 Hematologic Diseases Disorders of the blood and blood forming tissues. Blood Diseases,Hematological Diseases,Blood Disease,Disease, Blood,Disease, Hematologic,Disease, Hematological,Diseases, Blood,Diseases, Hematologic,Diseases, Hematological,Hematologic Disease,Hematological Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000740 Anemia A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. Anemias
D000741 Anemia, Aplastic A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. Anemia, Hypoplastic,Aplastic Anaemia,Aplastic Anemia,Anaemia, Aplastic,Aplastic Anaemias,Aplastic Anemias,Hypoplastic Anemia,Hypoplastic Anemias
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014391 Tuberculosis, Miliary An acute form of TUBERCULOSIS in which minute tubercles are formed in a number of organs of the body due to dissemination of the bacilli through the blood stream. Miliary Tuberculoses,Miliary Tuberculosis,Tuberculoses, Miliary

Related Publications

R M Glasser, and R I Walker, and J C Herion
November 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics,
R M Glasser, and R I Walker, and J C Herion
June 1987, Hematology/oncology clinics of North America,
R M Glasser, and R I Walker, and J C Herion
June 1987, Hematology/oncology clinics of North America,
R M Glasser, and R I Walker, and J C Herion
October 1970, Archives of internal medicine,
R M Glasser, and R I Walker, and J C Herion
January 2022, Bulletin of the National Research Centre,
R M Glasser, and R I Walker, and J C Herion
January 1995, Pneumonologia i alergologia polska,
R M Glasser, and R I Walker, and J C Herion
June 1987, Hematology/oncology clinics of North America,
R M Glasser, and R I Walker, and J C Herion
May 2024, JAMA dermatology,
R M Glasser, and R I Walker, and J C Herion
January 2016, The clinical respiratory journal,
R M Glasser, and R I Walker, and J C Herion
July 1999, Bulletin de la Societe de pathologie exotique (1990),
Copied contents to your clipboard!